Javeri Fiscal Services Ltd.

About Javeri

Equity

Derivatives

Mutual Funds

IPO

Corporate Info

Research

Contact Us

Corporate Info

Smart Quotes

Company Background

Board of Directors

Balance Sheet

Profit & Loss

Peer Comparison

Cash Flow

Shareholdings Pattern

Quarterly Results

Share Price

Deliverable Volume

Historical Volume

MF Holdings

Financial Ratios

Directors Report

Price Charts

Beta Analysis

Board Meetings

Corporate Announcements

Book Closure

Bonus

Company News

Dividend Details

Bulk Deals

Insider Trading

Advanced Chart

HOME > CORPORATE INFO > SMART QUOTES

Smart Quotes

Aurobindo Pharma Ltd.

Industry : Pharmaceuticals & Drugs

BSE Code	524804
ISIN Demat	INE406A01037
Book Value	369.16

NSE Code	AUROPHARMA
Dividend Yield %	0.00
Market Cap	691821.85

P/E	34.24
EPS	34.79
Face Value	1


	BSE		NSE

06-Feb-2026

Last Price	1191.15
Net Change	8.65
% Change	0.73%
Prev.Close	1182.50
Open	1174.75
High	1195.00
Low	1166.40
Volume	11909

Last Price	1191.00
Net Change	9.4
% Change	0.8%
Prev.Close	1181.60
Open	1181.00
High	1195.90
Low	1166.00
Volume	805359

Value	14014755
Best Buy	0.00
Best Sell	0.00
Best Quantity	0
Sell Quantity	0
Today's Range	1195.00
52-Week High	1278.00
52-Week Low	994.35

Value	949738788.4
Best Buy	0.00
Best Sell	0.00
Best Quantity	0
Sell Quantity	0
Today's Range	1195.90
52-Week High	1278.60
52-Week Low	1010.00

Open Price	1187.60
High Price	1197.90
Low Price	1170.10
Last Price	1194.60
Prev Close	1186.20
Change	8.40
% Change	0.71 %

Average Price	1181.91
Underlying Value	1191.00
Number of contracts traded	4560
Turnover in Rs. Lakhs	29642
Open Interest	20017250.00
Change in O I	-324500.00
% Change in O I	-1.60 %

Today

|

1W

|

1M

|

1Y

You need to upgrade your Flash Player

Best Bid

Best Offer

Quantity	0
Price	0.00

Quantity	0
Price	0.00

Best Bid

Best Offer

Quantity	0
Price	0.00

Quantity	0
Price	0.00

Best Bid

Best Offer

Quantity	550
Price	1194

Quantity	3300
Price	1197.8

Holding Details

Latest Corporate Events

Bonus

1 : 1

20-Jul-15

Book Closure

23-Aug-23

25-Aug-23

Dividend

400 %

08-Aug-25

Company News

07-02-2026

Aurobindo Pharma’s arm ge...

02-02-2026

Aurobindo Pharma informs...

02-02-2026

Clarification On Signifi...

01-02-2026

Clarification sought fro...

30-01-2026

Aurobindo Pharma informs...

09-01-2026

Aurobindo Pharma’s arm re...

02-01-2026

Aurobindo’s arm approves ...

Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores

Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: Click Here.